BACKGROUND: Maternal infection during pregnancy has been repeatedly associated with increased risk for schizophrenia. Nevertheless, most viruses do not cross the placenta; therefore, the damaging effects to the fetus appear to be related to maternal antiviral responses to infection (e.g. proinflammatory cytokines). Fetal exposure to the proinflammatory cytokine interleukin-8 (IL-8) has been significantly associated with risk of schizophrenia in offspring. This study sought to determine the association between fetal exposure to IL-8 and structural brain changes among schizophrenia cases and controls. METHODS: Subjects were 17 cases diagnosed with schizophrenia from the Developmental Insult and Brain Anomaly in Schizophrenia (DIBS) study. Psychiatric diagnoses were determined among offspring with semi-structured interviews and medical records review. IL-8 was determined from assays in archived prenatal sera and volumetric analyses of neuroanatomical regions were obtained from T1-weighted magnetic resonance imaging in adulthood. Eight controls were included for exploratory purposes. RESULTS: Among cases, fetal exposure to increases in IL-8 was associated with significant increases in ventricular cerebrospinal fluid, significant decreases in left entorhinal cortex volumes and significant decreases in right posterior cingulate volumes. Decreases that approached significance also were found in volumes of the right caudate, the putamen (bilaterally), and the right superior temporal gyrus. No significant associations were observed among controls. CONCLUSION: Fetal exposure to elevations in maternal IL-8 led to structural neuroanatomic alterations among cases in regions of the brain consistently implicated in schizophrenia research. In utero exposure to elevations in IL-8 may partially account for brain disturbances commonly found in schizophrenia. Copyright 2010 Elsevier B.V. All rights reserved.
BACKGROUND:Maternal infection during pregnancy has been repeatedly associated with increased risk for schizophrenia. Nevertheless, most viruses do not cross the placenta; therefore, the damaging effects to the fetus appear to be related to maternal antiviral responses to infection (e.g. proinflammatory cytokines). Fetal exposure to the proinflammatory cytokine interleukin-8 (IL-8) has been significantly associated with risk of schizophrenia in offspring. This study sought to determine the association between fetal exposure to IL-8 and structural brain changes among schizophrenia cases and controls. METHODS: Subjects were 17 cases diagnosed with schizophrenia from the Developmental Insult and Brain Anomaly in Schizophrenia (DIBS) study. Psychiatric diagnoses were determined among offspring with semi-structured interviews and medical records review. IL-8 was determined from assays in archived prenatal sera and volumetric analyses of neuroanatomical regions were obtained from T1-weighted magnetic resonance imaging in adulthood. Eight controls were included for exploratory purposes. RESULTS: Among cases, fetal exposure to increases in IL-8 was associated with significant increases in ventricular cerebrospinal fluid, significant decreases in left entorhinal cortex volumes and significant decreases in right posterior cingulate volumes. Decreases that approached significance also were found in volumes of the right caudate, the putamen (bilaterally), and the right superior temporal gyrus. No significant associations were observed among controls. CONCLUSION: Fetal exposure to elevations in maternal IL-8 led to structural neuroanatomic alterations among cases in regions of the brain consistently implicated in schizophrenia research. In utero exposure to elevations in IL-8 may partially account for brain disturbances commonly found in schizophrenia. Copyright 2010 Elsevier B.V. All rights reserved.
Authors: D L Collins; A P Zijdenbos; V Kollokian; J G Sled; N J Kabani; C J Holmes; A C Evans Journal: IEEE Trans Med Imaging Date: 1998-06 Impact factor: 10.048
Authors: Tyrone D Cannon; Theo G M van Erp; Isabelle M Rosso; Matti Huttunen; Jouko Lönnqvist; Tiia Pirkola; Oili Salonen; Leena Valanne; Veli-Pekka Poutanen; Carl-Gustav Standertskjöld-Nordenstam Journal: Arch Gen Psychiatry Date: 2002-01
Authors: Christos Pantelis; Dennis Velakoulis; Patrick D McGorry; Stephen J Wood; John Suckling; Lisa J Phillips; Alison R Yung; Edward T Bullmore; Warrick Brewer; Bridget Soulsby; Patricia Desmond; Philip K McGuire Journal: Lancet Date: 2003-01-25 Impact factor: 79.321
Authors: J I Nurnberger; M C Blehar; C A Kaufmann; C York-Cooler; S G Simpson; J Harkavy-Friedman; J B Severe; D Malaspina; T Reich Journal: Arch Gen Psychiatry Date: 1994-11
Authors: Alan S Brown; Jonathan Hooton; Catherine A Schaefer; Haiying Zhang; Eva Petkova; Vicki Babulas; Megan Perrin; Jack M Gorman; Ezra S Susser Journal: Am J Psychiatry Date: 2004-05 Impact factor: 18.112
Authors: Konasale M Prasad; Shaun M Eack; Dhruman Goradia; Krishna M Pancholi; Matcheri S Keshavan; Robert H Yolken; Vishwajit L Nimgaonkar Journal: Am J Psychiatry Date: 2011-06-01 Impact factor: 18.112
Authors: Juan A Gallego; Emily A Blanco; Sehba Husain-Krautter; E Madeline Fagen; Paula Moreno-Merino; Juan A Del Ojo-Jiménez; Anthony Ahmed; Thomas L Rothstein; Todd Lencz; Anil K Malhotra Journal: Schizophr Res Date: 2018-07-17 Impact factor: 4.939
Authors: Irene Knuesel; Laurie Chicha; Markus Britschgi; Scott A Schobel; Michael Bodmer; Jessica A Hellings; Stephen Toovey; Eric P Prinssen Journal: Nat Rev Neurol Date: 2014-10-14 Impact factor: 42.937
Authors: David Freedman; Raymond Deicken; Lawrence S Kegeles; Sophia Vinogradov; Yuanyuan Bao; Alan S Brown Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2011-05-03 Impact factor: 5.067
Authors: Jonathan L Hess; Daniel S Tylee; Rahul Barve; Simone de Jong; Roel A Ophoff; Nishantha Kumarasinghe; Paul Tooney; Ulrich Schall; Erin Gardiner; Natalie Jane Beveridge; Rodney J Scott; Surangi Yasawardene; Antionette Perera; Jayan Mendis; Vaughan Carr; Brian Kelly; Murray Cairns; Ming T Tsuang; Stephen J Glatt Journal: Schizophr Res Date: 2016-07-20 Impact factor: 4.939